Amplifon S.p.A Change in Accounts Receivable 2019-2024 | AMFPF
- Amplifon S.p.A change in accounts receivable for the quarter ending September 30, 2024 was $-0.001B, a 101.6% decline year-over-year.
- Amplifon S.p.A change in accounts receivable for the twelve months ending September 30, 2024 was $0.004B, a 92.52% decline year-over-year.
- Amplifon S.p.A annual change in accounts receivable for 2024 was $0.003B, a 106.38% decline from 2023.
- Amplifon S.p.A annual change in accounts receivable for 2023 was $-0.053B, a 124.2% increase from 2022.
- Amplifon S.p.A annual change in accounts receivable for 2022 was $-0.024B, a 764.6% decline from 2021.
Amplifon S.p.A Annual Change in Accounts Receivable (Millions of US $) |
|
---|---|
2024 | $3 |
2023 | $-53 |
2022 | $-24 |
2021 | $4 |
2020 | $38 |
2019 | $-37 |
2018 | $-28 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $5.378B | $2.607B |
Amplifon SpA provides hearing solutions and services. It operates principally in Italy, France, Spain, Portugal, Switzerland, Austria, Holland, the United States, Hungary and Egypt. Amplifon SpA is based in Milan, Italy. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $146.784B | 27.53 |
Elevance Health (ELV) | United States | $87.260B | 11.26 |
CVS Health (CVS) | United States | $83.934B | 10.43 |
Cencora (COR) | United States | $57.186B | 19.90 |
Natera (NTRA) | United States | $22.441B | 0.00 |
DiDi Global (DIDIY) | China | $22.121B | 23.50 |
BioMerieux (BMXMF) | France | $16.861B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $13.895B | 0.00 |
Solventum (SOLV) | United States | $12.853B | 13.61 |
ICON (ICLR) | Ireland | $11.879B | 11.04 |
CochLear (CHEOY) | Australia | $11.671B | 0.00 |
Revvity (RVTY) | United States | $11.280B | 19.41 |
Doximity (DOCS) | United States | $10.697B | 49.52 |
Viatris (VTRS) | United States | $10.669B | 3.67 |
Avantor (AVTR) | United States | $9.227B | 13.41 |
HealthEquity (HQY) | United States | $8.993B | 39.39 |
Medpace Holdings (MEDP) | United States | $8.737B | 23.21 |
Sonic Healthcare (SKHHY) | Australia | $8.503B | 0.00 |
Charles River Laboratories (CRL) | United States | $7.460B | 14.62 |
Bausch + Lomb (BLCO) | Canada | $4.400B | 25.92 |
BrightSpring Health Services (BTSG) | United States | $3.797B | 34.84 |
Sotera Health (SHC) | United States | $3.335B | 18.95 |
Alignment Healthcare (ALHC) | United States | $2.983B | 0.00 |
Surgery Partners (SGRY) | United States | $2.961B | 38.50 |
Concentras Parent (CON) | United States | $2.793B | 16.14 |
Organon (OGN) | United States | $2.618B | 2.78 |
Ardent Health (ARDT) | United States | $1.938B | 8.26 |
GeneDx Holdings (WGS) | United States | $1.894B | 72.93 |
Premier (PINC) | United States | $1.855B | 14.08 |
Progyny (PGNY) | United States | $1.847B | 40.66 |
PACS (PACS) | United States | $1.614B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.600B | 32.00 |
Teladoc Health (TDOC) | United States | $1.258B | 0.00 |
Pediatrix Medical (MD) | United States | $1.224B | 9.31 |
Establishment Labs Holdings (ESTA) | $1.073B | 0.00 | |
CareDx (CDNA) | United States | $1.048B | 16.37 |
Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
Agilon Health (AGL) | United States | $0.907B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $0.828B | 7.75 |
QDM (QDMI) | Hong Kong, SAR China | $0.763B | 0.00 |
Nutex Health (NUTX) | United States | $0.694B | 10.51 |
Embecta (EMBC) | United States | $0.587B | 3.95 |
LifeMD (LFMD) | United States | $0.577B | 0.00 |
Enhabit (EHAB) | United States | $0.505B | 41.54 |
InnovAge Holding (INNV) | United States | $0.498B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.469B | 10.57 |
Sonida Senior Living (SNDA) | United States | $0.467B | 0.00 |
SBC Medicals (SBC) | United States | $0.464B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.423B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.257B | 0.00 |
Oncology Institute (TOI) | United States | $0.236B | 0.00 |
Beauty Health (SKIN) | United States | $0.197B | 0.00 |
DocGo (DCGO) | United States | $0.154B | 25.17 |
KindlyMD (KDLY) | United States | $0.150B | 0.00 |
Pheton Holdings (PTHL) | China | $0.111B | 0.00 |
KindlyMD (NAKA) | United States | $0.102B | 0.00 |
So-Young (SY) | China | $0.095B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.087B | 0.00 |
OncoCyte (OCX) | United States | $0.077B | 0.00 |
Sera Prognostics (SERA) | United States | $0.067B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.055B | 0.00 |
ModivCare (MODV) | United States | $0.048B | 0.00 |
Biodesix (BDSX) | United States | $0.044B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
INVO Fertility (IVF) | United States | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |